About Geneoscopy
Geneoscopy develops noninvasive tests for gastrointestinal diseases. The company uses its stool-derived eukaryotic RNA (seRNA) technology platform to create tests for colorectal cancer screening and other GI diseases. Geneoscopy's customers are patients and healthcare providers.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $105,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $105,000,000 · Series-B+
- Capital Raise
Raised $6,900,000 · Series-A
- Milestone
X account created (@GeneoscopyCo)
417 followers
- Milestone
Website domain registered
geneoscopy.com
- Milestone
Company founded
St Louis, United States
Investors & Backers
Funding History
Founders & Leadership
Andrew Barnell
Chief Executive Officer & Co-founder
Erica Barnell
Chief Medical & Science Officer, Co-founder
Eric Duncavage
Chief Medical Officer
Haytham Gareer
Chief Medical Officer
Mathew Sargent
Chief Commercial Officer
Yiming Kang
Founder
Press Coverage & Sources
fundraisingfox.com/companies/geneoscopy-inc
prnewswire.com/news-releases/geneoscopy-closes-105m-in-financing-to-advance-its-noninvasive-multifactor-rna-screening-test-for-colorectal-cancer-prevention-301424501.html
finsmes.com/2019/10/geneoscopy-raises-6-9m-in-series-a-funding.html
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com